pentobarbital will lessen the level or outcome of fentanyl intranasal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Intently. Coadministration of fentanyl with CYP3A4 inducers could lead to your minimize in fentanyl plasma concentrations, deficiency of efficacy or, potentially, development of a withdrawal syndrome